Stent Restenosis    Long-Term Clinical Outcomes after Sirolimus-Eluting Stent Implantation for Treatment of Restenosis within Bare-Metal Versus Drug-Eluting Stents Catheter Cardiovasc Interv (2008) 71;594-8 C. Whan Lee, et al. Stent Fracture, an Incidental Finding or a Significant Marker of Clinical in-Stent Restenosis? Catheter Cardiovasc Interv (2008) 71;614-8 F. Shaikh, et al. Optimal Treatment of Renal Artery in-Stent Restenosis: Repeat Stent Placement Versus Angioplasty Alone Catheter Cardiovasc Interv (2008) 71;701-5 Z. M. N'Dandu, et al. Predictors of in-Stent Restenosis and Patient Outcome after Percutaneous Coronary Intervention in Patients with Diabetes Mellitus Am J Cardiol (2007) 100;777-80 R. Sukhija, et al. Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction after Paclitaxel-Eluting and Bare Metal Stent Implantation Circulation (2007) 115;2842-7 G. W. Stone, et al. Routine Upstream Initiation Vs Deferred Selective Use of Glycoprotein Iib/Iiia Inhibitors in Acute Coronary Syndromes: The Acuity Timing Trial JAMA (2007) 297;591-602 G. W. Stone, et al. Impact of in-Stent Restenosis on Death and Myocardial Infarction Am J Cardiol (2007) 100;1109-13 D. H. Steinberg, et al. Comparison of Effectiveness of Bare Metal Stents Versus Drug-Eluting Stents in Large (> or =3.5 Mm) Coronary Arteries Am J Cardiol (2007) 99;599-602 D. H. Steinberg, et al. Thoracic Radiotherapy in Patients with Lymphoma and Restenosis after Coronary Stent Placement Catheter Cardiovasc Interv (2007) 70;359-65 K. Schomig, et al. Dual-Source Coronary Computed Tomography Angiography for Detecting in-Stent Restenosis Heart (2007) F. Pugliese, et al. Long-Term Outcomes after Management of Restenosis or Thrombosis of Drug-Eluting Stents J Am Coll Cardiol (2007) 49;181-4 G. J. Mishkel, et al. Comparison of Six-Month Angiographic and Three-Year Outcomes after Sirolimus-Eluting Stent Implantation Versus Brachytherapy for Bare Metal in-Stent Restenosis Am J Cardiol (2007) 100;425-30 S. W. Lee, et al. Factors Predictive of Cardiac Events and Restenosis after Sirolimus-Eluting Stent Implantation in Small Coronary Arteries Catheter Cardiovasc Interv (2007) 69;821-5 C. W. Lee, et al. Incidence and Predictors of Recurrent Restenosis Following Implantation of Drug-Eluting Stents for in-Stent Restenosis Catheter Cardiovasc Interv (2007) 69;104-8 C. W. Lee, et al. Recruitable Collateral Blood Flow Index Predicts Coronary Instent Restenosis after Percutaneous Coronary Intervention Eur Heart J (2007) 28;1820-6 L. O. Jensen, et al. Late Target Lesion Revascularization after Implantation of Sirolimus-Eluting Stent Catheter Cardiovasc Interv (2007) M. K. Hong, et al. The Impact of Lesion Length and Vessel Size on Outcomes after Sirolimus-Eluting Stent Implantation for in-Stent Restenosis Heart (2007) S. Habara, et al. Treatment of Drug-Eluting Stent Restenosis with the Same Versus Different Drug-Eluting Stent Catheter Cardiovasc Interv (2007) 70;9-14 S. Garg, et al. Diagnostic Accuracy of Coronary in-Stent Restenosis Using 64-Slice Computed Tomography: Comparison with Invasive Coronary Angiography J Am Coll Cardiol (2007) 49;951-9 M. Ehara, et al. Effectiveness of Drug-Eluting Stents in Patients with Bare-Metal in-Stent Restenosis: Meta-Analysis of Randomized Trials J Am Coll Cardiol (2007) 49;616-23 A. Dibra, et al. Relocation of Minimal Luminal Diameter after Bare Metal and Drug-Eluting Stent Implantation: Incidence and Impact on Angiographic Late Loss Catheter Cardiovasc Interv (2007) 69;181-8 M. A. Costa, et al. Repeated Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis: The Same or a Different Stent Am Heart J (2007) 153;354-9 J. Cosgrave, et al. Enhanced Inflammatory Response to Coronary Stenting Marks the Development of Clinically Relevant Restenosis Catheter Cardiovasc Interv (2007) 69;500-7 A. M. Caixeta, et al. Usefulness of 64-Slice Multislice Computed Tomography Coronary Angiography to Assess in-Stent Restenosis J Am Coll Cardiol (2007) 49;2204-10 F. Cademartiri, et al.